Peter Kolchinsky, Director, 10% Owner at Artiva Biotherapeutics, Inc. (ARTV), bought 8,863,340 shares at $12.00 ($104.7M) on 2024-07-22, disclosed to the SEC on 2024-07-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 68,320 | $0 | 0.0% |
| 2 | $10.20 | 138,506 | $1.4M | 1.3% |
| 3 | $10.20 | 323,181 | $3.3M | 3.1% |
| 4 | $12.00 | 688,326 | $8.3M | 7.9% |
| 5 | $12.00 | 7,645,007 | $91.7M | 87.6% |
| Total | $11.81 avg | 8,863,340 |
| $104.7M |
| 100% |
| Filing → |
| VOR | SELL | 2025-10-30 | $20.7M | — | Filing → |
| CDTX | BUY | 2025-06-30 | $100.0M | — | Filing → |
| TYRA | BUY | 2025-06-06 | $23.5M | — | Filing → |